Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health Catalyst (HCAT) Cost of Revenue (2018 - 2025)

Historic Cost of Revenue for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to $38.5 million.

  • Health Catalyst's Cost of Revenue fell 899.49% to $38.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $169.1 million, marking a year-over-year increase of 218.41%. This contributed to the annual value of $165.8 million for FY2024, which is 103.59% up from last year.
  • As of Q3 2025, Health Catalyst's Cost of Revenue stood at $38.5 million, which was down 899.49% from $42.5 million recorded in Q2 2025.
  • Health Catalyst's 5-year Cost of Revenue high stood at $44.9 million for Q4 2024, and its period low was $27.3 million during Q1 2021.
  • Moreover, its 5-year median value for Cost of Revenue was $38.5 million (2025), whereas its average is $38.0 million.
  • In the last 5 years, Health Catalyst's Cost of Revenue skyrocketed by 3586.56% in 2021 and then plummeted by 899.49% in 2025.
  • Health Catalyst's Cost of Revenue (Quarter) stood at $33.9 million in 2021, then grew by 12.48% to $38.1 million in 2022, then increased by 16.98% to $44.6 million in 2023, then increased by 0.76% to $44.9 million in 2024, then decreased by 14.27% to $38.5 million in 2025.
  • Its Cost of Revenue was $38.5 million in Q3 2025, compared to $42.5 million in Q2 2025 and $43.2 million in Q1 2025.